Baird Medical Investment (BDMD) Stock Price, News & Analysis

Company Overview

ExcelFin Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. ExcelFin Acquisition Corp. is based in San Francisco, California.

Key Stats

• Today's Range: $2.10 to $2.48
• 50-Day Range: N/A
• 52-Week Range: $2.10 to $7.88
• Volume: 50,813 shs
• Average Volume: 42,399 shs
• Market Capitalization: $14.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BDMD Stock Analysis - Frequently Asked Questions

How have BDMD shares performed this year?

Baird Medical Investment's stock was trading at $4.32 on January 1st, 2024. Since then, BDMD shares have decreased by 47.9% and is now trading at $2.25.
View the best growth stocks for 2024 here.

How do I buy shares of Baird Medical Investment?

Shares of BDMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Baird Medical Investment own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Baird Medical Investment investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:BDMD
• Previous Symbol: NASDAQ:BDMD
• CUSIP: N/A
• CIK: 1982444
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $33.05 million
• Price / Sales: 0.45
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,584,000
• Free Float: 1,389,000
• Market Cap: $14.81 million
• Optionable: N/A
• Beta: 0.15